Literature DB >> 10816502

Role of hyphal formation in interactions of Candida albicans with endothelial cells.

Q T Phan1, P H Belanger, S G Filler.   

Abstract

The ability to change from yeast to hyphal morphology is a major virulence determinant of Candida albicans. Mutants with defined defects in filamentation regulatory pathways have reduced virulence in mice. However, is it poorly understood why hyphal formation is critical for C. albicans to cause hematogenously disseminated infections. We used recently constructed mutants to examine the role of hyphal formation in the interactions of C. albicans with endothelial cells in vitro. These interactions included the ability of the mutants to invade and injure endothelial cells. Because the formation of hyphae may influence the host inflammatory response to C. albicans, we also investigated the capacity of these mutants to stimulate endothelial cells to express E-selectin and intercellular adhesion molecule 1. We infected endothelial cells with C. albicans strains containing homozygous null mutations in the following filamentation regulatory genes: CLA4, CPH1, EFG1, and TUP1. Whereas the wild-type strain formed true hyphae on endothelial cells, we found that neither the Deltaefg1 nor the Deltacph1 Deltaefg1 double mutant germinated. The Deltatup1 mutant formed only pseudohyphae. We also found that the Deltaefg1, Deltacph1 Deltaefg1, and Deltatup1 mutants had significantly reduced capacities to invade and injure endothelial cells. Therefore, Efg1p and Tup1p contribute to virulence by regulating hyphal formation and the factors that enable C. albicans to invade and injure endothelial cells. With the exception of the Deltacph1 Deltaefg1 mutant, all other mutants stimulated endothelial cells to express at least one of the leukocyte adhesion molecules. Therefore, the combined activities of Cph1p and Efg1p are required for C. albicans to stimulate a proinflammatory response in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816502      PMCID: PMC97632          DOI: 10.1128/IAI.68.6.3485-3490.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Regulatory networks controlling Candida albicans morphogenesis.

Authors:  A J Brown; N A Gow
Journal:  Trends Microbiol       Date:  1999-08       Impact factor: 17.079

2.  Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells.

Authors:  A S Ibrahim; S G Filler; D Sanglard; J E Edwards; B Hube
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

4.  Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection.

Authors:  A S Orozco; X Zhou; S G Filler
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

6.  Endothelial cell injury caused by Candida albicans is dependent on iron.

Authors:  R A Fratti; P H Belanger; M A Ghannoum; J E Edwards; S G Filler
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  The contribution of the O-glycosylated protein Pir2p/Hsp150 to the construction of the yeast cell wall in wild-type cells and beta 1,6-glucan-deficient mutants.

Authors:  J C Kapteyn; P Van Egmond; E Sievi; H Van Den Ende; M Makarow; F M Klis
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

8.  Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene.

Authors:  C I Hoover; M J Jantapour; G Newport; N Agabian; S J Fisher
Journal:  FEMS Microbiol Lett       Date:  1998-10-15       Impact factor: 2.742

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans.

Authors:  S D Leidich; A S Ibrahim; Y Fu; A Koul; C Jessup; J Vitullo; W Fonzi; F Mirbod; S Nakashima; Y Nozawa; M A Ghannoum
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

View more
  76 in total

1.  Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans.

Authors:  Martin Zavrel; Olivia Majer; Karl Kuchler; Steffen Rupp
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Efg1-mediated recruitment of NuA4 to promoters is required for hypha-specific Swi/Snf binding and activation in Candida albicans.

Authors:  Yang Lu; Chang Su; Xuming Mao; Prashna Pala Raniga; Haoping Liu; Jiangye Chen
Journal:  Mol Biol Cell       Date:  2008-08-06       Impact factor: 4.138

Review 3.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

4.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

5.  SR-like RNA-binding protein Slr1 affects Candida albicans filamentation and virulence.

Authors:  Chaiyaboot Ariyachet; Norma V Solis; Yaoping Liu; Nemani V Prasadarao; Scott G Filler; Anne E McBride
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

6.  Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro.

Authors:  Angela A Sanchez; Douglas A Johnston; Carter Myers; John E Edwards; Aaron P Mitchell; Scott G Filler
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Rapid Phenotypic and Genotypic Diversification After Exposure to the Oral Host Niche in Candida albicans.

Authors:  Anja Forche; Gareth Cromie; Aleeza C Gerstein; Norma V Solis; Tippapha Pisithkul; Waracharee Srifa; Eric Jeffery; Darren Abbey; Scott G Filler; Aimée M Dudley; Judith Berman
Journal:  Genetics       Date:  2018-05-03       Impact factor: 4.562

8.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

9.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

10.  An internal polarity landmark is important for externally induced hyphal behaviors in Candida albicans.

Authors:  Alexandra Brand; Anjalee Vacharaksa; Catherine Bendel; Jennifer Norton; Paula Haynes; Michelle Henry-Stanley; Carol Wells; Karen Ross; Neil A R Gow; Cheryl A Gale
Journal:  Eukaryot Cell       Date:  2008-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.